Peers of CRISPR Therapeutics AG (CRSP)
Health Care · Biotechnology
Market cap divided by free cash flow over the last 12 months. Shows how many dollars investors pay for each $1 of yearly cash.
Latest P/FCF Ratio
-12.93x
As of Oct 22, 2026
Beyond P/FCF Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/FCF Ratio |
|---|---|
| Oct 22, 2026 | -12.93x |
| Oct 21, 2026 | -13.06x |
| Oct 20, 2026 | -12.90x |
| Oct 19, 2026 | -12.94x |
| Oct 16, 2026 | -12.74x |
| Oct 15, 2026 | -13.32x |
| Oct 14, 2026 | -12.99x |
| Oct 13, 2026 | -12.96x |
P/FCF Ratio = Market Capitalization / Free Cash Flow (TTM)
P/FCF focuses on actual cash generation rather than accounting profit.
Read the general P/FCF Ratio definition, formula, and analyst usage guide.
P/FCF Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
